Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
LendingTree
TREE
$461M
| $20.6M | ﹤0.01% |
67,831
+1,007
| +2% | +$333K |
|
1702
Trinity Industries
TRN
$2.34B
| $20.5M | ﹤0.01% |
925,141
-62,289
| -6% | -$1.27M |
|
1703
Acco Brands
ACCO
$399M
| $20.5M | ﹤0.01% |
2,185,863
-24,111
| -1% | -$228K |
|
|
CCXI
1704
DELISTED
ChemoCentryx, Inc.
CCXI
| $20.4M | ﹤0.01% |
516,720
+12,799
| +3% | +$225K |
|
|
ANAT
1705
DELISTED
American National Group, Inc. Common Stock
ANAT
| $20.4M | ﹤0.01% |
173,646
-104,856
| -38% | -$12.4M |
|
1706
Santander
BSBR
$43.2B
| $20.4M | ﹤0.01% |
1,756,858
-10,464
| -0.6% | -$112K |
|
|
INST
1707
DELISTED
Instructure, Inc.
INST
| $20.4M | ﹤0.01% |
423,271
-9,126
| -2% | -$428K |
|
|
UNIT
1708
Uniti Group
UNIT
$2.38B
| $20.4M | ﹤0.01% |
2,484,356
-418,342
| -14% | -$3.03M |
|
1709
Rambus
RMBS
$10.8B
| $20.3M | ﹤0.01% |
1,474,964
-27,199
| -2% | -$365K |
|
1710
Cactus
WHD
$5.78B
| $20.3M | ﹤0.01% |
591,178
-23,723
| -4% | -$720K |
|
|
SNBR
1711
DELISTED
Sleep Number
SNBR
| $20.2M | ﹤0.01% |
411,235
-18,305
| -4% | -$870K |
|
1712
NovaGold Resources
NG
$3.4B
| $20.2M | ﹤0.01% |
2,259,532
-76,274
| -3% | -$528K |
|
|
RAVN
1713
DELISTED
Raven Industries Inc
RAVN
| $20.1M | ﹤0.01% |
584,654
-19,700
| -3% | -$672K |
|
1714
Magna International
MGA
$18.7B
| $20.1M | ﹤0.01% |
367,226
-979
| -0.3% | -$53.1K |
|
|
BPFH
1715
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $20M | ﹤0.01% |
1,665,551
-24,617
| -1% | -$285K |
|
1716
United Parks & Resorts
PRKS
$2.04B
| $20M | ﹤0.01% |
631,730
-21,146
| -3% | -$610K |
|
|
RARX
1717
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $20M | ﹤0.01% |
426,577
-10,335
| -2% | -$457K |
|
1718
Compass Diversified
CODI
$924M
| $20M | ﹤0.01% |
803,988
+2,416
| +0.3% | +$53.3K |
|
1719
Nu Skin
NUS
$236M
| $20M | ﹤0.01% |
487,513
+7,371
| +2% | +$301K |
|
1720
JELD-WEN Holding
JELD
$170M
| $20M | ﹤0.01% |
853,340
-20,954
| -2% | -$431K |
|
1721
Gentherm
THRM
$1.32B
| $20M | ﹤0.01% |
449,476
-14,796
| -3% | -$630K |
|
|
GRA
1722
DELISTED
W.R. Grace & Co.
GRA
| $19.9M | ﹤0.01% |
285,463
+2,588
| +0.9% | +$174K |
|
|
NAV
1723
DELISTED
Navistar International
NAV
| $19.9M | ﹤0.01% |
687,543
-3,306
| -0.5% | -$102K |
|
1724
Alcoa
AA
$13.1B
| $19.9M | ﹤0.01% |
923,234
-491,713
| -35% | -$10.2M |
|
|
RC
1725
Ready Capital
RC
$294M
| $19.8M | ﹤0.01% |
1,283,967
+31,389
| +3% | +$494K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.